Encompass Health Corp. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Net Sales

1,597.40

1,586.60

1,544.60

1,477.50

1,457.70

1,455.40

1,405.00

Other Operating Income

0.00

Total Operating income

1,597.40

1,586.60

1,544.60

1,477.50

1,457.70

1,455.40

1,405.00

Raw Material Cost

1,246.40

1,226.80

1,192.80

1,177.80

1,139.20

1,136.10

1,118.20

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

820.30

818.10

801.10

784.80

767.70

762.30

756.80

Power Cost

0.00

Manufacturing Expenses

32.80

31.80

30.20

30.80

30.40

31.80

33.00

Selling and Distribution Expenses

62.60

58.20

68.40

56.10

59.40

52.30

54.50

Other Expenses

-85.31

-84.99

-83.13

-81.56

-79.81

-79.41

-78.98

Total Expenditure (Excl Depreciation)

1,309.00

1,285.00

1,261.20

1,233.90

1,198.60

1,188.40

1,172.70

Operating Profit (PBDIT) excl Other Income

288.4

301.6

283.4

243.6

259.1

267

232.3

Other Income

6.90

19.30

4.50

7.10

8.10

3.40

2.30

Operating Profit (PBDIT)

385.70

408.20

374.30

333.10

347.10

349.60

312.60

Interest

32.80

31.80

30.20

30.80

30.40

31.80

33.00

Exceptional Items

-0.90

-0.40

0.00

-0.20

Gross Profit (PBDT)

351.00

359.80

351.80

299.70

318.50

319.30

286.80

Depreciation

90.40

87.30

86.40

82.40

79.90

79.20

78.00

Profit Before Tax

261.60

288.70

257.70

219.90

236.80

238.60

201.40

Tax

53.60

56.40

55.40

44.90

51.00

41.60

37.60

Provisions and contingencies

0.00

Profit After Tax

154.10

178.10

144.90

126.60

142.60

151.60

119.70

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

154.10

178.10

144.90

126.60

142.60

151.60

119.70

Share in Profit of Associates

0.00

Minority Interest

53.50

53.70

57.00

48.10

42.80

45.00

43.30

Other related items

0.00

Consolidated Net Profit

207.60

231.80

201.90

174.70

185.40

196.60

163.00

Equity Capital

0.00

Face Value

0.01

Reserves

2,597.70

2,521.70

2,438.20

2,373.80

2,280.10

2,159.10

2,067.00

Earnings per share (EPS)

1.54

1.93

1.43

1.24

1.39

1.48

1.18

Diluted Earnings per share

1.54

1.93

1.43

1.24

1.39

1.48

1.18

Operating Profit Margin (Excl OI)

18.05%

19.01%

18.35%

16.49%

17.77%

18.35%

16.53%

Gross Profit Margin

22.04%

23.7%

22.28%

20.46%

21.73%

21.84%

19.89%

PAT Margin

9.65%

11.23%

9.38%

8.57%

9.78%

10.42%

8.52%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.68% vs 2.72% in Mar 2026

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -10.44% vs 14.81% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -2.60% vs 5.16% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is 3.14% vs 5.30% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Encompass Health Corp. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

1,597.40

1,420.46

176.94

12.46%

Other Operating Income

0.00

Total Operating income

1,597.40

1,420.46

176.94

12.46%

Raw Material Cost

1,246.40

1,362.23

-115.83

-8.50%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

820.30

0.00

820.30

Power Cost

0.00

Manufacturing Expenses

32.80

1.81

30.99

1,712.15%

Selling and Distribution Expenses

62.60

48.12

14.48

30.09%

Other Expenses

-85.31

-0.18

-85.13

-47,294.44%

Total Expenditure (Excl Depreciation)

1,309.00

1,410.35

-101.35

-7.19%

Operating Profit (PBDIT) excl Other Income

288.40

10.11

278.29

2,752.62%

Other Income

6.90

27.76

-20.86

-75.14%

Operating Profit (PBDIT)

385.70

44.66

341.04

763.64%

Interest

32.80

1.81

30.99

1,712.15%

Exceptional Items

-0.90

-6.11

5.21

85.27%

Gross Profit (PBDT)

351.00

58.23

292.77

502.78%

Depreciation

90.40

6.79

83.61

1,231.37%

Profit Before Tax

261.60

29.94

231.66

773.75%

Tax

53.60

0.03

53.57

178,566.67%

Provisions and contingencies

0.00

Profit After Tax

154.10

29.92

124.18

415.04%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

154.10

29.92

124.18

415.04%

Share in Profit of Associates

0.00

Minority Interest

53.50

0.00

53.50

Other related items

0.00

Consolidated Net Profit

207.60

29.92

177.68

593.85%

Equity Capital

0.00

Face Value

0.01

0.00

Reserves

2,597.70

181.43

2,416.27

1,331.79%

Earnings per share (EPS)

1.54

1.80

-0.26

-14.44%

Diluted Earnings per share

1.54

1.80

-0.26

-14.44%

Operating Profit Margin (Excl OI)

18.05%

0.71%

0.00

17.34%

Gross Profit Margin

22.04%

2.59%

0.00

19.45%

PAT Margin

9.65%

2.11%

0.00

7.54%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 159.74 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is 0.68% vs 2.72% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 9.58% vs 12.03% in Jun 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 20.76 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is -10.44% vs 14.81% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 11.97% vs 26.21% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 37.88 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is -2.60% vs 5.16% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 11.74% vs 17.50% in Jun 2025

Quarterly - Interest

Interest 3.28 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is 3.14% vs 5.30% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 7.89% vs -11.37% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.05%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025